openPR Logo
Press release

Preimplantation Genetic Diagnosis - Saving Offsprings From Any Genetic Disorder

07-29-2016 12:59 PM CET | Health & Medicine

Press release from: Transparency Market Research

Preimplantation Genetic Diagnosis - Saving Offsprings From Any

The market for preimplantation genetic diagnosis (PGD) in Asia features high fragmentation when it comes to diagnostic service providers. The large number of local players has intensified the competitive rivalry in the region.

However, owing to the lack of better alternatives to PGD, costs of these procedures remain high, a major limiting factor for the market, especially in cost-sensitive developing countries in the region. A recent report by TMR suggests that the rising preference to assisted reproductive techniques and flourishing medical tourism industry will help the Asia PGD market gain sustained business in the near future.

Interpret a Competitive outlook Analysis Report with free PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=9989

Rising Preference for Assisted Reproductive Techniques to be Key Enabler of PGD Market in Asia

Rising preference to assisted reproductive techniques, which involve preimplantation genetic diagnosis as a standard course of action for ensuring that the embryo is free of any genetic anomalies, is central to the healthy growth of the Asia PGD market. The demand for assisted reproductive techniques in the region is driven majorly due to two factors: delayed age of conception among women and the alarmingly rising rate of infertility in the region.

With rising participation in the region’s workforce, a significant number of Asian women are conceiving their babies in late 20s to late 30s. As infertility issues and challenges concerned with conceiving start intensifying as the age rises, couples in the region are increasingly preferring assisted reproductive techniques such as in vitro fertilization.

Rate of infertility in countries such as China and India has substantially increased in the past few years. Xinhua, one of China’s prominent news agencies has stated that around 12.5% of China’s population was infertile in 2010. In India too, around 10% of the population was said to be suffering from infertility in 2013. Considering the total population of over 2.5 bn of these two countries, the number of infertile people in these countries is massive. Thus, the potential for rise in numbers of assisted reproductive techniques and, correspondingly, in the number of PGD tests is massive in Asia.

Southern Asia to Provide Most Attractive Growth Opportunities

Owing to the controversial nature of PGD techniques, they are not offered at all healthcare centers and are banned in entirety or are limited to the scanning of some specific genetic traits only. In most Asian countries where PGD is not prohibited, it is controlled by the regional or national government. The high costs of PGD techniques are also an area of immense concern for certain cost sensitive countries in the region. Combined with liberal regulatory norms and the rising population of high-earning individuals, Southern Asia will emerge as the most lucrative market for preimplantation genetic diagnosis in the next few years.

The PGD market in Southern Asia is expected to rise at a favorable 7.9% CAGR from 2015 to 2023. During the same period, the market for PGD in Central and Western Asia is expected to witness sluggish development owing to lower penetration of advanced technologies in the healthcare industries and stringent guidelines related to PGD tests in the regions.
As a whole, the Asia preimplantation genetic diagnosis market, which had a valuation of US$16.0 mn in 2014, will exhibit a CAGR of 6.8% from 2015 to 2023, and rise to US$28.8 mn by 2023.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Preimplantation Genetic Diagnosis - Saving Offsprings From Any Genetic Disorder here

News-ID: 352639 • Views: 299

More Releases from Transparency Market Research

Latest TMR Report Explores Impact of COVID-19 Outbreak on Wine Market
Wine is an alcoholic beverage made from grapes, without the addition of acids, enzymes, sugars, water, and other nutrients. Yeast helps in the consumption of the sugar in the grapes and converts it into carbon dioxide and ethanol. Different yeasts and different varieties of grapes produce different types of wine. The variations in wine result from the complex interaction between the biochemical developments of the grapes. Obtain Report Details @ https://www.transparencymarketresearch.com/wine-market.html Grapes
Coronavirus's Impact On Healthcare Electronic Data Interchange (EDI) Market
Electronic data interchange is a concept of electronic business communication. Healthcare electronic data interchange allows the interchange of computer-processable electronic healthcare data in a user-friendly format among healthcare institutions, healthcare professionals, and patients. Standardization, cost savings, improved productivity, and faster processing are some of the benefits offered by healthcare EDI. Obtain Report Details @ https://www.transparencymarketresearch.com/healthcare-electronic-data-interchange-market.html For instance, healthcare providers can send claim status requests and procure information using a predefined transaction
Sputum Collection Containers Market Research, Recent Trends and Growth Forecast
Sputum Collection Container Market: Overview The global sputum collection containers market represents promising opportunities for pharmaceutical manufacturers during the forecast period. Sputum collection containers are used to collect a biological sample of sputum during transit. Sputum collection containers find applications in hospitals, research, and development centers and diagnostic centers. Sputum collection containers generally include a leak-proof screw cap wide moth closure for convenient use. Obtain Report Details @ https://www.transparencymarketresearch.com/sputum-collection-containers-market.html Manufacturers engaged in
Potential Impact of COVID-19 on Anti-Counterfeiting Packaging Market
Anti-counterfeiting Packaging Market: Overview Counterfeits are unauthorized reproductions of a trademarked brand which are identical to genuine products. Counterfeit goods include clothing, jewelry, medications, cigarettes, electronic equipment and parts among others. Secure packaging is necessary to avoid counterfeit products. Anti-counterfeiting packaging is defined as the process of assigning secure packaging to the product in order to minimize infringement and counterfeiting. Obtain Report Details @ https://www.transparencymarketresearch.com/anti-counterfeiting-packaging-market.html The market for counterfeit goods is growing

All 5 Releases


More Releases for PGD

Preimplantation Genetics Diagnosis (PGD) Market: Increasing Demand for Efficient …
The world PGD market is expected to witness notable growth in the coming years owning to the rising prevalence of genetic, hereditary and chromosomal diseases. Moreover, PGD have high chances of conceiving healthy embryos. However, the high costs incurred in the PGD technologies hamper the growth of the market. Moreover, stringent government regulations and ethical concerns also obstruct the growth of the market. In coming years, there would be increase
Global Preimplantation Genetics Diagnosis (PGD) Market Analysis Report 2019 by S …
Preimplantation genetic diagnosis (PGD) also referred to as embryo screening, is a branch of genetics involves in genetic testing of the embryo through In-Vitro Fertilization (IVF). PGD eliminates the risk of selective pregnancy termination for couples who are at substantial risk of transferring serious genetic, chromosomal or hereditary disorders such as spinal muscular atrophy and cystic fibrosis. Get the sample report: https://www.alliedmarketresearch.com/request-sample/1470?utm_source=openpr&utm_medium=Niranjan Preimplantation Genetic Diagnosis Market Report, published by Allied Market Research,
Latest Research on Preimplantation Genetics Diagnosis (PGD) Market 2018 Global A …
The latest report published on Up Market Research, on Preimplantation Genetics Diagnosis (PGD) Market Analysis offers comprehensive analysis, delivering detailed market data and penetrating insights. The report covers detailed Preimplantation Genetics Diagnosis (PGD) Market analysis by Product, Application, Region, Major Player, Market Size, Share, Trends, Growth and Forecast 2018-2025. Get Free Sample Copy Of This Report @ https://www.upmarketresearch.com/home/requested_sample/7016 The Preimplantation Genetics Diagnosis (PGD) Market report published on Up Market Research is spread
Global Preimplantation Genetic Diagnosis (PGD) Market is Anticipated to Reach US …
A new Transparency Market Research report states that the global preimplantation genetic diagnosis (PGD) market stood at US$77.2 mn in 2013 and is anticipated to reach US$118 mn by 2020, by expanding at a CAGR of 6.28% from 2014 to 2020. The title of the report is “Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.” Preimplantation genetic diagnosis (PGD) is the genetic
Global Preimplantation Genetic Diagnosis Market (PGD) to Reach $121.50 Million b …
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Preimplantation Genetic Diagnosis Market “ Get Free Sample Report @ https://www.mrrse.com/sample/1351 Since the last two decades, preimplantation genetic diagnosis (PGD) has been used to detect chromosomal aneuploidy in low prognosis patients who undergo in-vitro fertilization (IVF). PGD is now being used to detect a broader
Preimplantation Genetic Diagnosis Market : Asia PGD Market To Witness Highest Tr …
Rising numbers of assisted reproductive procedures such as in vitro fertilization (IVF) is Asia is the most prominent factor driving the market for preimplantation genetic diagnosis. This is, in essence, the result of factors such as the delayed age of conception among Asian women, the rising rate of infertility among the population, and the significantly expanding medical tourism industry in the region. Rising disposable incomes and increased awareness regarding the